16 afleveringen
Q&A with FDA U.S. Food and Drug Administration, Center for Drug Evaluation and Research
-
- Gezondheid en fitness
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
-
The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad
Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.
-
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.
-
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
-
Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng
Listen to our latest podcast series, Q&A with FDA, on Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng.
-
FDA’s Regulation of Dietary Supplements with Dr. Cara Welch
Listen to our latest podcast series, Q&A with FDA - FDA’s Regulation of Dietary Supplements featuring Dr. Cara Welch.
-
A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska
Listen to our latest podcast series, Q&A with FDA, on A Step Forward in the Treatment of Opioid and Alcohol Dependence featuring Dr. Iilun Murphy and Dr. Marta Sokolowska.